Data-Driven Deal: Biosero and Virscidian Double Down on Drug Discovery

As part of a collaboration and co-marketing agreement, Biosero, Inc., a developer of laboratory automation solutions to coordinate scientific discoveries, and Virscidian, a developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, will support completely automated analytical workflows for medicinal chemistry as well as other scientific applications, such as accelerated drug discovery screening.

Software Takes Over!

To hasten the process of finding new drugs, Virscidian created the Analytical Studio platform, which includes the software packages Analytical Studio Professional^TM and Analytical Studio Express^TM. The program automates the processing of chromatographic and mass spectrometric data to produce valuable intel, including the determination and quantification of chemicals of interest, the selection of the best analytical and preparative LC/MS settings, reaction tracking, and so much more. Additionally, it offers users sorted lists of results to make choosing what actions to take next and which compounds to advance in the research and development pipeline easier. To organize, synchronize, and monitor the physical flow of materials, the management of instruments, and the digital transfer of data on workstations or throughout large laboratory facilities, Biosero offers Green Button Go^® laboratory automation software.

Two is Better Than One

Full medicinal chemistry and analytical workflows can be automated thanks to the collaboration between Biosero and Virscidian, which makes it simple for users to move data between both software platforms. Which compounds move on to the next step, which instruments are utilized to operate them, and under what circumstances can all be controlled by software-powered conversion of analytical data into decisions that can be taken. The use of human involvement can be decreased or eliminated thanks to this method, which allows for the testing and progression of additional chemicals into follow-up studies. Customers are already reaping the rewards of Biosero and Virscidian’s collaboration on more than ten projects now underway in various parts of the globe.

Executive Exegesis

CEO Joseph Simpkins of Virscidian highlights the company’s goal of providing specific insights that optimizes chemical synthesis, purification, and screening so that scientists may focus on the work that is most important to them without sacrificing laboratory efficiency. He understands that the company’s partnership with Biosero expands clients’ access to a verified Green Button Go plugin that smoothly combines Virscidian’s analysis-based intelligence with the capacity to physically operate the scientific process and instrumentation in full conformity.

It has become obvious that there is a growing demand in biopharma businesses to digitize medicinal chemistry applications and expedite compound screening in areas like DMPK, according to Ryan Bernhardt, Chief Commercial Officer at Biosero, who made the comment based on the group’s work tasks with clients in the drug research and development area. With the support of Biosero, which connects the latter’s software platforms, Bernhardt is happy to announce that its partnership with Virscidian will speed up the drug discovery process for customers from synthesis to registered material and screening findings.

About Biosero, Inc.

The BICO group company Biosero creates science-focused software and lab automation solutions that let researchers plan their discoveries at every level. By aligning laboratory automation with science using Biosero’s Green Button Go^® Scheduler software and integration services, operations are sped up and productivity is raised. A complete laboratory management solution is also offered by Green Button Go Orchestrator applications, which manage workflows and activities in the life sciences, biotechnology, pharmaceutical, and diagnostic research fields. Biosero is excited about working with groups committed to improving life by meeting the most pressing needs in the world. Visit www.biosero.com for additional details.

About Virscidian

The privately held company called Virscidian is made up of specialists in finding, creating, and putting into practice decision-driven solutions to boost efficiency in biopharmaceutical and agricultural production networks. Independent of the vendor equipment, patrons can computerize reaction screening, end-to-end filtration, affinity collection by mass spectrometry, compound quality management, drug metabolism and pharmacokinetics, and other high-throughput methodological approaches with the aid of Virscidian’s scientific analytical desktop and business applications. Their technologies enable chemists and project teams to make tough judgments from massive amounts of data with assurance in the outcomes. This enhances productivity and the quality of findings. Their products are simple to integrate and give some of the most advanced automation platforms in the world the crucial choices they need.

Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CpE

Editor-in-Chief, PharmaFEATURES